Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 79

Gut microbes release cancer-fighting bile acids that block hormone signals

Bacteria naturally present in the human intestine (known as the gut microbiota) can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators. The study was published on April 15 in Cell.

“I was very surprised by our findings. As far as I know, no one has previously discovered molecules like these bile acids that can interact with the androgen receptor in this way,” said co-senior author Dr. Chun-Jun Guo, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology and a scientist at the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine.

Dr. David Artis, director of the Jill Roberts Institute and the Friedman Center for Nutrition and Inflammation and the Michael Kors Professor in Immunology, and Dr. Nicholas Collins, assistant professor of immunology in medicine, both at Weill Cornell Medicine, are co-senior authors of the study. Drs. Wen-Bing Jin, formerly a postdoctoral associate, and Leyi Xiao, a current postdoctoral associate in Dr. Guo’s lab, are the co-first authors of the study.

Founder interview: Dr. Emil Kendziorra, Founder & CEO at Tomorrow Biostasis

In our Founder Interview series, we highlight the brightest minds in preventive health, wellness, and longevity. In Episode 6, we’re honored to feature Dr. Emil Kenziorra, founder and CEO at Tomorrow Biostasis —one of the world-leading human cryopreservation experts.

Tell us a little about yourself and your current venture

Doctor and researcher by training, entrepreneur by trade. Longevity has always been my motivation, with a focus on maximal life span extension. I’m running Tomorrow.bio and the non-profit European Biostasis Foundation to push human cryopreservation forward.

Betavoltaic cell with perovskite-radioactive isotope combo can power long-term applications

A research team has developed the world’s first next-generation betavoltaic cell by directly connecting a radioactive isotope electrode to a perovskite absorber layer. By embedding carbon-14-based quantum dots into the electrode and enhancing the perovskite absorber layer’s crystallinity, the team achieved both stable power output and high energy conversion efficiency.

The work is published in the journal Chemical Communications. The team was led by Professor Su-Il In of the Department of Energy Science & Engineering at DGIST.

The newly developed technology offers a stable, long-term power supply without the need for recharging, making it a promising next-generation energy solution for fields requiring long-term power autonomy, such as , , and military applications.

Microbubble dynamics in boiling water enable precision fluid manipulation

A watched pot never boils, goes the old saying, but many of us have at least kept an eye on the pot, waiting for the bubbling to start. It’s satisfying to finally see the rolling boil, behind which complex physical mechanisms are at play.

When this happens, the that form continuously change in shape and size. These dynamic movements influence the surrounding fluid flow, thereby affecting the efficiency of heat transfer from the to the water.

Manipulating small amounts of liquid at high speeds and frequencies is essential for processing large numbers of samples in medical and chemical fields, such as in cell sorting. Microbubble vibrations can create flows and sound waves, aiding in liquid manipulation. However, the and interactions of multiple bubbles is poorly understood, so their applications have been limited.

Is your heart aging too fast? MRI technique reveals how unhealthy lifestyles can add decades

Scientists at the University of East Anglia (UEA) have developed a new way of uncovering the “true age” of a heart using MRI.

Research accepted for publication European Heart Journal Open shows how an MRI scan can reveal your heart’s functional age—and how unhealthy lifestyles can dramatically accelerate this figure. The paper is titled “Cardiac MRI Markers of Ageing: A Multicentre, Cross-sectional Cohort Study.”

It is hoped that the findings could transform how heart disease is diagnosed—offering a lifeline to millions by catching problems before they become deadly.

Lysosome destabilization found to drive iron-dependent cell death in cancer

The duplication and division of cells is critical to keeping all multicellular organisms alive. But the opposite process is equally important: cell death. Controlled death of cells, or programmed cell death, is also necessary for the proper development and function of the body. It has also been a focus of researchers developing treatments for cancer by finding ways to activate the cell death of cancer cells themselves.

Ferroptosis is a recently discovered form of programmed and has been a promising target for the development of cancer treatments. It is mediated by iron molecules, with the cell dying through the degradation of the phospholipid bilayer by oxidation, a process called . However, recent studies have shown that certain cancer cells are less susceptible to ferroptosis, raising concerns that this resistance could pose a barrier to future therapeutics.

In a paper published in Nature Communications, researchers from Kyushu University, using cultured cells and mice, found that the lipid peroxidation of the lysosomes—the organelle responsible for degrading and recycling molecules in a cell—plays a critical role in the execution of ferroptosis.

Making AI models more trustworthy for high-stakes contexts, like classifying diseases in medical images

Antimicrobial resistance (AMR) presents a serious challenge in today’s world. The use of antimicrobials (AMU) significantly contributes to the emergence and spread of resistant bacteria. Companion animals gain recognition as potential reservoirs and vectors for transmitting resistant microorganisms to both humans and other animals. The full extent of this transmission remains unclear, which is particularly concerning given the substantial and growing number of households with companion animals. This situation highlights critical knowledge gaps in our understanding of risk factors and transmission pathways for AMR transfer between companion animals and humans. Moreover, there’s a significant lack of information regarding AMU in everyday veterinary practices for companion animals. The exploration and development of alternative therapeutic approaches to antimicrobial treatments of companion animals also represents a research priority. To address these pressing issues, this Reprint aims to compile and disseminate crucial additional knowledge. It serves as a platform for relevant research studies and reviews, shedding light on the complex interplay between AMU, AMR, and the role of companion animals in this global health challenge. This Reprint is especially addressed to companion animal veterinary practitioners as well as all researchers working on the field of AMR in both animals and humans, from a One Health perspective.

Predicting relapse of autoimmune small vessel vasculitis

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, these cells are also active in autoimmune diseases. New research has found that a certain subpopulation of these white blood cells can predict disease relapse at an early stage, which may enable improved personalized treatment.

In a study published in Nature Communications, a multi-institutional research team investigated which cell types dominate the blood of patients at the early stage of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, which is caused by inflammation in the blood vessels and can disrupt organ function.

“Figuring out the mechanism of this disease, which is poorly understood, will help us understand autoimmune dysregulation in neutrophils. This could aid in the development of new drugs tailored for each patient,” says the lead author of the study. “Because we want to understand the dynamics of neutrophil behavior at the cell level in the early stages of the disease, for this study we recruited new patients that had not yet been treated.”